December 3, 2018
The Japanese CNS drug market is expected to shrink in 2026, but sales of attention-deficit, hyperactivity disorder (ADHD) treatments are projected to rise to 51.4 billion yen, up 50.7% against 2017, according to Fuji Keizai. As a whole, the CNS...read more